Bruno Eymard Selected Research

Implantable Defibrillators (Implantable Cardioverter-Defibrillator)

1/2019	Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.
1/2017	Risk for Complications after Pacemaker or Cardioverter Defibrillator Implantations in Patients with Myotonic Dystrophy Type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Eymard Research Topics

Disease

32	Muscular Diseases (Myopathy) 01/2023 - 10/2003
16	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 11/2023 - 03/2003
15	Myasthenia Gravis 01/2021 - 10/2004
10	Congenital Structural Myopathies (Centronuclear Myopathy) 12/2023 - 11/2005
8	Muscle Weakness 04/2019 - 07/2007
8	Myotonic Dystrophy (Dystrophia Myotonica) 12/2018 - 10/2003
7	Distal Myopathies (Distal Muscular Dystrophy) 01/2023 - 12/2008
7	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 08/2007
5	Nemaline Myopathies (Nemaline Myopathy) 01/2022 - 12/2013
5	Dysferlinopathy 01/2021 - 08/2005
4	Inclusion Body Myositis 01/2021 - 10/2003
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 11/2004
4	Atrophy 01/2020 - 09/2004
4	Myofibrillar Myopathy 06/2018 - 07/2005
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2016 - 06/2011
4	Autoimmune Diseases (Autoimmune Disease) 02/2014 - 10/2004
3	Arthrogryposis 10/2023 - 05/2014
3	Thymoma (Thymic Carcinoma) 01/2020 - 02/2006
3	Disease Progression 01/2018 - 06/2007
3	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017 - 09/2003
3	type 2B Limb-girdle muscular dystrophy 02/2009 - 08/2005
2	Rare Diseases (Rare Disease) 06/2024 - 01/2023
2	Bethlem myopathy 01/2021 - 10/2010
2	Scleroatonic muscular dystrophy 01/2021 - 10/2010
2	Malignant Hyperthermia 01/2021 - 11/2017
2	Muscle Hypotonia (Hypotonia) 01/2021 - 03/2009
2	Central Core Myopathy (Central Core Disease) 01/2021 - 11/2017
2	Fibrosis (Cirrhosis) 08/2019 - 04/2015
2	Neuromuscular Diseases (Neuromuscular Disease) 08/2019 - 03/2013
2	Hearing Loss (Hearing Impairment) 01/2018 - 05/2014
2	Glycogen Storage Disease Type III (Cori's Disease) 11/2017 - 05/2015
2	Glycogen Storage Disease (Glycogenosis) 10/2017 - 08/2010
2	Neoplasms (Cancer) 09/2017 - 01/2016
2	Neuromuscular Junction Diseases 09/2017 - 09/2014
2	Foot Deformities (Foot Deformity) 01/2017 - 05/2014
2	Sudden Death 01/2017 - 11/2015
2	Dermatomyositis (Dermatopolymyositis) 01/2016 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 06/2015
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2015 - 12/2013
2	Sarcoglycanopathies 04/2015 - 02/2012
2	Cap Myopathy 07/2014 - 12/2013
2	Respiratory Insufficiency (Respiratory Failure) 05/2014 - 07/2011
2	Oculopharyngeal Muscular Dystrophy 01/2014 - 08/2006
2	Thymus Hyperplasia 03/2013 - 10/2004
2	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 04/2010 - 03/2009
2	Myotonic Disorders (Paramyotonia Congenita) 04/2010 - 09/2004
2	Paralysis (Palsy) 03/2009 - 11/2004
2	Miyoshi myopathy 02/2009 - 08/2005
2	Protein Deficiency 02/2009 - 08/2007
2	Ophthalmoplegia (External Ophthalmoplegia) 06/2007 - 03/2003
2	Myotonia 09/2006 - 11/2004
1	Progressive Multifocal Leukoencephalopathy 07/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2005
10	Cholinergic ReceptorsIBA 11/2023 - 01/2004
10	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 08/2007
9	AutoantibodiesIBA 01/2018 - 10/2003
8	AntibodiesIBA 10/2023 - 08/2007
5	ConnectinIBA 12/2018 - 12/2008
4	Protein Isoforms (Isoforms)IBA 10/2023 - 09/2004
4	AgrinIBA 10/2022 - 08/2009
4	CollagenIBA 01/2021 - 10/2004
4	DystrophinIBA 08/2019 - 11/2004
4	Sodium Channels (Sodium Channel)IBA 04/2015 - 10/2004
4	DysferlinIBA 02/2009 - 08/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2003
3	CalciumIBA 01/2020 - 02/2013
3	Biomarkers (Surrogate Marker)IBA 08/2019 - 02/2014
3	DesminIBA 06/2018 - 07/2005
3	Signal Recognition ParticleIBA 01/2018 - 07/2011
3	GlycogenIBA 12/2017 - 09/2003
3	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 11/2004
3	muskIBA 01/2013 - 12/2004
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 10/2003
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 11/2017
2	Extracellular Matrix ProteinsIBA 01/2021 - 10/2010
2	Protein AggregatesIBA 06/2018 - 06/2010
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 02/2014
2	Complement System Proteins (Complement)IBA 01/2018 - 10/2003
2	Rituximab (Mabthera)FDA Link 01/2018 - 03/2017
2	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 11/2017 - 05/2015
2	Calcium Channels (Calcium Channel)IBA 09/2017 - 11/2004
2	EnzymesIBA 08/2017 - 08/2010
2	AntigensIBA 02/2017 - 08/2007
2	human GAA protein (Myozyme)FDA Link 01/2017 - 07/2011
2	CalpainIBA 01/2016 - 12/2015
2	Mitochondrial DNA (mtDNA)IBA 11/2015 - 06/2007
2	Sarcoglycans (beta Sarcoglycan)IBA 04/2015 - 02/2012
2	SodiumIBA 04/2015 - 11/2004
2	Dynamin IIIBA 12/2014 - 11/2005
2	Proteoglycans (Proteoglycan)IBA 09/2014 - 12/2013
2	TropomyosinIBA 07/2014 - 12/2013
2	Messenger RNA (mRNA)IBA 03/2014 - 02/2014
2	SteroidsIBA 06/2011 - 06/2008
2	ChloridesIBA 09/2006 - 11/2004
2	peripheral membrane protein 43KIBA 10/2004 - 01/2004

Therapy/Procedure

7	Therapeutics 06/2024 - 05/2005
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019 - 01/2017
2	Activities of Daily Living (ADL) 01/2018 - 01/2017
2	Enzyme Replacement Therapy 01/2017 - 07/2011
2	Heart Transplantation (Grafting, Heart) 11/2015 - 12/2013